Q32 Bio Inc. (NASDAQ: QTTB) shares shot up 171% to $5.91 after the company sold its Phase 2 complement inhibitor ADX-097 to Akebia for $12 million upfront and potential milestone and royalty payments …
Dow Dips 200 Points; Q32 Bio Shares Jump
view original post